Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

NCT07311330 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)
Erectile Dysfunction

Interventions

DRUG: YN001 20mg Dose + 5% glucose injection
OTHER: 5% glucose injection

Sponsor

Beijing Inno Medicine Co., Ltd.